11 results
COVID-19 - SARSCOV2 Variants
 • B.1.17 - 501Y.V1
 • B.1.351 - 501Y.V2
 • P.1 - 501Y.V3

#COVID19
COVID-19 - SARSCOV2 ... - 501Y.V2 • P.1 ... - 501Y.V3 #COVID19 ... #SARSCOV2 #Variants ... #comparison #table
Summary of Pharmacology for Select Proposed COVID-19 Treatments

#Pharmacology #Dosing #Table #COVID19 #Coronavirus #SARSCOV2 #Medications #JAMA
Select Proposed COVID ... -19 Treatments ... Pharmacology #Dosing #Table ... #COVID19 #Coronavirus ... #SARSCOV2 #Medications
COVID-19 - A Seattle Intensivist's One-Page Cheat-Sheet on COVID-19 v2.7 Updated March 26 2020

(v2.7) incorporating newer
as data on new treatment ... US and updated treatment ... clarified the treatment ... in Seattle 2020-1- ... Management #Summary #SARSCoV2
COVID-19 patient Extubation
Objective: Extubation of a suspected COVID-19 patient whilst minimising aersolisation of virus particles. Orly
COVID-19 patient ... of a suspected COVID ... PPE required 1) ... extubate on theatre table ... #CriticalCare #SARSCoV2
Remdesivir (GS-5734) - manufactured by Gilead Sciences
Remdesivir blocks the replication of viruses by inserting into the
being copied. 1. ... #Pharmacology #Pathophysiology ... #COVID19 #SARSCOV2
Rhabdomyolysis - Differential Diagnosis and Management Summary

Trauma:
 • Immobilization, Crush iniury, Compartment syndrome, Electrical injury
Exertional:
 •
Dermatomyositis) AKI - Pathophysiology ... : 1. ... oxidative iniury Treatment ... per day until stable ... Summary #causes #treatment
Persistence of clinically relevant viruses on dry inanimate surfaces

Most common viruses persist on surfaces for days
Influenza virus 1 ... Parvovirus > 1 ... viruses #surfaces #infectiousdiseases ... #diagnosis #table ... contagiousness #COVID19
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Perforation) Pathophysiology ... Epidemiology: • #1 ... 10 mg/kg IV x 1 ... IDSA 2021 CDI Treatment ... #infectiousdiseases
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
Epidemiology: • 1- ... Guillain-Barre Pathophysiology ... like illnesses, COVID ... main variants: (1) ... Treatment: • Plasmapheresis
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
Lung Abscess Pathophysiology ... : 1. ... antibiotics once stable ... hemorrhage • Treatment ... shows a small, stable